These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11908945)

  • 1. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens.
    Pontes-de-Carvalho L; Santana CC; Soares MB; Oliveira GG; Cunha-Neto E; Ribeiro-dos-Santos R
    J Autoimmun; 2002 Mar; 18(2):131-8. PubMed ID: 11908945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice.
    Tibbetts RS; McCormick TS; Rowland EC; Miller SD; Engman DM
    J Immunol; 1994 Feb; 152(3):1493-9. PubMed ID: 8301148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection.
    Cardillo F; Falcão RP; Rossi MA; Mengel J
    Eur J Immunol; 1993 Oct; 23(10):2597-605. PubMed ID: 8405060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
    Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
    Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease.
    Leon JS; Wang K; Engman DM
    J Immunol; 2003 Oct; 171(8):4271-7. PubMed ID: 14530351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease.
    Elias FE; Vigliano CA; Laguens RP; Levin MJ; Berek C
    Am J Trop Med Hyg; 2003 Feb; 68(2):242-7. PubMed ID: 12641419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
    Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
    J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
    Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM
    Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cardiac histopathology in inbred mouse strains chronically infected with Trypanosoma cruzi.
    Rowland EC; Lozykowski MG; McCormick TS
    J Parasitol; 1992 Dec; 78(6):1059-66. PubMed ID: 1491299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation.
    Silva JS; Rossi MA
    J Exp Pathol (Oxford); 1990 Feb; 71(1):33-9. PubMed ID: 2138024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart damage comparing three strains of mice chronically infected with Trypanosoma cruzi.
    Morales MC; Cardoni RL; Rimoldi MT; Esteva M; Milei J
    Medicina (B Aires); 1987; 47(5):493-9. PubMed ID: 3333075
    [No Abstract]   [Full Text] [Related]  

  • 15. Captopril ameliorates myocarditis in acute experimental Chagas disease.
    Leon JS; Wang K; Engman DM
    Circulation; 2003 May; 107(17):2264-9. PubMed ID: 12707246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody.
    Yuan HT; Liao YH; Wang Z; Dong JH; Cao LS; Wang ZH; Wang JP; Fu ML
    Can J Physiol Pharmacol; 2003 Feb; 81(2):84-8. PubMed ID: 12710519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection.
    Cutrullis RA; Poklépovich TJ; Postan M; Freilij HL; Petray PB
    Int Immunopharmacol; 2011 Aug; 11(8):1024-31. PubMed ID: 21371583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity in Chagas' heart disease.
    Cunha-Neto E; Kalil J
    Sao Paulo Med J; 1995; 113(2):757-66. PubMed ID: 8650474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and acquired immunity in the pathogenesis of Chagas disease.
    Golgher D; Gazzinelli RT
    Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin and significance of anti-heart and anti-skeletal muscle autoantibodies in Chagas' disease.
    Laguens RP; Cabeza Meckert P; Chambo J
    Res Immunol; 1991 Feb; 142(2):160-3. PubMed ID: 1714090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.